Portfolio News

Reform RX and CFM teams

Acquisition of Pilates experts ReformRX marks first exit for Investment Fund for Northern Ireland Equity Fund

Pilates reformer manufacturer Reform RX has become the first exit for the Investment Fund for Northern Ireland (IFNI) after the company was acquired by US-based connected fitness equipment leader iFIT Inc for an undisclosed sum.

The IFNI was launched by The British Business Bank to tackle an identified funding gap, with the aim of driving sustainable economic growth by supporting innovation and creating opportunities for new and scaling businesses.

Acquisition of Pilates experts ReformRX marks first exit for Investment Fund for Northern Ireland Equity Fund Read More »

Three men on a balcony

First equity deal announced for £70m Investment Fund for Northern Ireland

Clarendon Fund Managers leads investment for data solutions firm INQDATA A data solutions company which hails Northern Ireland as a global centre of excellence when it comes to the talent of engineers has received £750,000 funding from the Investment Fund for Northern Ireland’s equity arm. The investment round into Belfast headquartered, INQDATA was led by

First equity deal announced for £70m Investment Fund for Northern Ireland Read More »

Ann-Marie Slavin and Siobhan Donaghy

Modern Democracy ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in

Portfolio company, Modern Democracy, ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in.Congratulations to Siobhan Donaghy and her team on delivering this great result for the recent GB elections. The below article is taken from: https://syncni.com/article/11966/derry-based-company-ensures-smooth-gb-elections-for-4-5m-voters-as-record-number-of-councils-adopt-digital-check-in Derry-based company Modern Democracy is forecasting further growth ahead of the

Modern Democracy ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in Read More »

Neurovalens closes £2.1m funding round

Neurovalens, a Belfast-headquartered specialist in non-invasive neuro-technology, has closed a £2.1m funding round with existing investors in preparation for a $40m-$50m Series B fundraising round. The firm has also received clearance from the US Food & Drug Administration (FDA) for its Modius Stress device. The below article is taken from: https://www.insidermedia.com/news/ireland/neurovalens-closes-2.1m-funding-round?utm_source=ireland_newsletter&utm_campaign=ireland_news_tracker&utm_medium=deals_article The company, whose medical

Neurovalens closes £2.1m funding round Read More »

The Boatyard Distillery Awarded No.6 in Drinks International’s Bartenders’ Choice

Congratulations to portfolio company, The Boatyard Distillery and, in particular, Joe McGirr and Declan McGurk, on this significant recognition. The Drinks International Report is seen as the global authority for the spirits world with the top 100 bars globally contributing to its publication. Boatyard climbed the rankings of both the top trending Vodka and Gin lists, and also made

The Boatyard Distillery Awarded No.6 in Drinks International’s Bartenders’ Choice Read More »

CV6 Receive MHRA Approval for UK-Wide Trials

Congratulations to portfolio company, CV6 Therapeutics, (NI) Ltd. and, in particular, Robert D. Ladner, Ph.D. on this significant commercial milestone. We look forward to following developments with interest as the company commences its first-in-human clinical trial. Article taken from: CV6 Therapeutics Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial (yahoo.com) CV6 Therapeutics

CV6 Receive MHRA Approval for UK-Wide Trials Read More »

Neurovalens Receive FDA Clearance for its Modius Sleep Device

Congratulations to portfolio company, Neurovalens, and its CEO, Jason McKeown, on receiving clearance from the FDA on its Modius Sleep device for the treatment of chronic insomnia! A big milestone for the company – well done to the whole Neurovalens team! Article taken from: https://www.massdevice.com/fda-clears-insomnia-treating-device-neurovalens/ Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic

Neurovalens Receive FDA Clearance for its Modius Sleep Device Read More »

ANGOKA TO REVEAL NEXT GENERATION SECURITY TO PROTECT “LAST MILE” COMMUNICATIONS

Belfast-based cyber security leader ANGOKA is to unveil a new solution which offers robust security in the face of emerging quantum threats about to confront our daily lives. Article taken from: https://angoka.io/angoka-to-reveal-next-generation-security-to-protect-last-mile-communications/ The new technology provides quantum-secure last mile key exchange (the security of data fundamentally relies on a secure exchange of cryptographic keys between

ANGOKA TO REVEAL NEXT GENERATION SECURITY TO PROTECT “LAST MILE” COMMUNICATIONS Read More »

Respiratory Analytics – Health Innovation Research Alliance Northern Ireland’s Company of the Month

Respiratory Analytics won Health Innovation Research Alliance NI’s company of the month for its technology that helps people with Asthma and COPD to correctly take their inhaled medicines. Article taken from: https://uk.linkedin.com/company/health-innovation-research-alliance-northern-ireland-hirani?trk=organization_guest_main-feed-card_reshare_feed-actor-name HIRANI’s September company of the month is Respiratory Analytics. Founded in November 2019 by Dr Susan Kelly (CEO), Professor Jim Harkin Professor Liam

Respiratory Analytics – Health Innovation Research Alliance Northern Ireland’s Company of the Month Read More »